sall1

Migration, Crosslink

📖

sall1

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-sall1

📖 Wiki Page

gene1646 wordssynced 2026-04-02

sall1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">sall1</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>Tissue Expression</td>
</tr>
<tr>
<td class="label">SALL1</td>
<td>Brain (microglia), kidney, ear</td>
</tr>
<tr>
<td class="label">SALL2</td>
<td>Ubiquitous</td>
</tr>
<tr>
<td class="label">SALL3</td>
<td>Brain, other tissues</td>
</tr>
<tr>
<td class="label">SALL4</td>
<td>Stem cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>

SALL1 (Spalt-like transcription factor 1) is a zinc-finger transcription factor that plays critical roles in embryonic development and cellular differentiation. In the adult brain, SALL1 has emerged as a key regulator of microglial identity and function. The SALL1 gene is located on chromosome 16q12.1 and encodes a protein with multiple zinc-finger domains that enable sequence-specific DNA binding and transcriptional regulation.

...

sall1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">sall1</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>Tissue Expression</td>
</tr>
<tr>
<td class="label">SALL1</td>
<td>Brain (microglia), kidney, ear</td>
</tr>
<tr>
<td class="label">SALL2</td>
<td>Ubiquitous</td>
</tr>
<tr>
<td class="label">SALL3</td>
<td>Brain, other tissues</td>
</tr>
<tr>
<td class="label">SALL4</td>
<td>Stem cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>

SALL1 (Spalt-like transcription factor 1) is a zinc-finger transcription factor that plays critical roles in embryonic development and cellular differentiation. In the adult brain, SALL1 has emerged as a key regulator of microglial identity and function. The SALL1 gene is located on chromosome 16q12.1 and encodes a protein with multiple zinc-finger domains that enable sequence-specific DNA binding and transcriptional regulation.

Microglia, the resident immune cells of the central nervous system (CNS), play essential roles in brain development, maintenance, and disease. SALL1 has been identified as one of the most specific markers for microglia in the adult brain and is critical for maintaining microglial identity and function. The loss of SALL1 expression in microglia is associated with pathological changes in Alzheimer's disease and other neurodegenerative conditions.

Gene Structure and Organization

Genomic Location

Chromosome: 16
Band: 16q12.1
Genomic coordinates: Approximately 51,180,000-51,250,000 (GRCh38)
Gene length: Approximately 70 kb
Exons: Multiple exons encoding the full-length protein

Protein Structure

The SALL1 protein contains several key structural features:

N-terminal domain: Transcription repression domain

Zinc-finger domains: Multiple C2H2-type zinc fingers for DNA binding

Sal domain: Conserved domain involved in protein-protein interactions

C-terminal region: Regulatory and interaction domains

The zinc-finger domains allow SALL1 to bind to specific DNA sequences and regulate the transcription of target genes. The Sal domain is named after the Drosophila "spalt" gene, which shares homology with SALL family members.

SALL Family

The SALL family of transcription factors consists of four members in mammals:

SALL1 is unique among family members in its highly restricted expression in adult microglia, making it a specific microglial marker.

Microglial Biology

Origin

Microglia derive from embryonic yolk sac progenitors that colonize the brain during early development. This distinct origin distinguishes microglia from other tissue macrophages and contributes to their unique transcriptional profile.

Functions in the Healthy Brain

In the healthy brain, microglia perform essential functions:

Synaptic pruning: Phagocytic removal of excess synapses during development

Neuronal support: Release of trophic factors supporting neuronal survival

Brain homeostasis: Monitoring and maintenance of CNS environment

Immune surveillance: Constant scanning for pathogens or damage

Microglial States

Microglia exist in a spectrum of activation states:

Surveying: Resting state with highly motile processes
Activated: Response to injury or pathogens
Disease-associated: Pathological states in neurodegeneration

SALL1 in Microglia

Expression Pattern

SALL1 is one of the most specific markers for microglia in the adult brain:

Highly expressed in all microglial subpopulations
Maintained in adult microglia throughout life
Not expressed in neurons, astrocytes, or oligodendrocytes
Specific to brain microglia compared to peripheral macrophages

Transcriptional Regulation

SALL1 regulates microglial identity by:

Direct gene activation: Binding to regulatory regions of microglial genes

Chromatin remodeling: Modifying chromatin accessibility

Repression of alternative fates: Suppressing macrophage-like programs

Maintenance of microglial genes: Sustaining the microglial transcriptional program

Key Target Genes

SALL1 regulates numerous microglial genes including:

Tmem119: transmembrane protein 119 (microglial marker)
P2ry12: Purinergic receptor for microglial surveillance
Cx3cr1: Fractalkine receptor
Tgfbr1: TGF-beta receptor
Igf1: Insulin-like growth factor 1

SALL1 in Disease

Alzheimer's Disease

SALL1 dysfunction is strongly implicated in Alzheimer's disease pathogenesis:

Disease-Associated Microglia (DAM)

In Alzheimer's disease, microglia adopt a disease-associated phenotype:

Loss of SALL1 expression is a hallmark of DAM transition
DAM lose microglial identity markers
Gain of phagocytic and inflammatory functions

Mechanisms of SALL1 Loss

The mechanisms underlying SALL1 loss in AD include:

Amyloid-beta effects: Aβ exposure reduces SALL1 expression
Tau pathology: Phosphorylated tau affects microglial transcription
Epigenetic changes: DNA methylation alterations
Inflammatory signals: Chronic inflammation promotes DAM transition

Therapeutic Implications

Restoring SALL1 expression in microglia may provide benefits:

Maintenance of microglial identity
Reduction of harmful inflammation
Enhancement of physiological functions
Potential for disease modification

Parkinson's Disease

SALL1 alterations in Parkinson's disease include:

Microglial Activation

Altered SALL1 expression in PD brains
Contributes to neuroinflammation
May affect dopaminergic neuron survival

Alpha-synuclein Pathology

α-Synuclein aggregates activate microglia
SALL1 expression changes in response
Contributes to chronic inflammation

Brain Development

SALL1 plays roles in brain development:

Embryonic Development

Regulates neural stem cell function
Influences neuronal differentiation
Controls microglial colonization of brain

Postnatal Development

Essential for synaptic pruning
Regulates brain wiring
Maintains developmental plasticity

Other Neurological Conditions

SALL1 dysregulation is observed in:

Multiple sclerosis: Altered microglial SALL1 in lesions
Amyotrophic lateral sclerosis: Microglial SALL1 changes
Stroke: SALL1 response to ischemic injury
Traumatic brain injury: Microglial activation pattern

SALL1 in Development

Kidney Development

SALL1 is essential for kidney development:

Controls ureteric bud branching
Regulates nephron formation
Mutations cause renal malformations

Ear Development

SALL1 is expressed in the developing ear:

Inner ear morphogenesis
Auditory neuron development
Vestibular system formation

Limb Development

SALL1 affects limb development:

Digital formation
Tissue patterning
Limb bud growth

Townes-Brocks Syndrome

Clinical Features

Townes-Brocks syndrome is caused by SALL1 mutations:

Renal anomalies: Kidney malformations, renal agenesis

Ear abnormalities: Preauricular tags, hearing loss

Thumb anomalies: Triphalangeal thumbs, thumb duplication

Anal atresia: Imperforate anus

Cardiac defects: Various congenital heart defects

Foot anomalies: Flat feet, toe malformations

Genetics

Inheritance: Autosomal dominant
Gene: SALL1
Mechanism: Haploinsufficiency (loss-of-function mutations)
Penetrance: Variable expressivity

Diagnosis

Townes-Brocks syndrome is diagnosed clinically:

Characteristic physical features
Family history
Genetic testing for SALL1 mutations

Management

Management involves:

Surgical correction of anomalies
Hearing assessment and treatment
Renal function monitoring
Multidisciplinary care

Molecular Mechanisms

Transcriptional Regulation

SALL1 functions as a transcriptional regulator through:

DNA binding: Zinc-finger domains recognize specific sequences

Transcriptional activation: N-terminal transactivation domain

Protein interactions: Forms complexes with other transcription factors

Chromatin modification: Recruits chromatin remodelers

Epigenetic Regulation

SALL1 influences epigenetic states:

Histone modification patterns
DNA methylation maintenance
Chromatin accessibility

Signaling Pathways

SALL1 interacts with key signaling pathways:

TGF-β signaling: Regulates TGF-beta receptor expression
Wnt signaling: Cross-talk with Wnt pathway
Notch signaling: Developmental Notch-SALL1 interactions
Fractalkine signaling: Cx3cr1 regulation

Therapeutic Approaches

Targeting Microglial SALL1

Therapeutic strategies include:

SALL1 expression modulators:

Epigenetic drugs affecting SALL1
Transcription factor activators

Microglial function enhancers:

Agents promoting physiological microglial functions
Anti-inflammatory approaches

Disease-modifying strategies:

Combined approaches targeting amyloid/tau and microglia
Immunomodulatory therapies

Gene Therapy

Future approaches may include:

Viral vector delivery of SALL1
CRISPR-based gene editing
mRNA delivery

Animal Models

Mouse Models

SALL1 mouse models have revealed:

SALL1 knockout is embryonic lethal
Heterozygous mice show developmental defects
Conditional knockout reveals microglial functions
AD models show SALL1 alterations

Zebrafish Models

Zebrafish studies demonstrate:

Evolutionary conservation
Microglial colonization patterns
Developmental functions

SALL1 and Microglial Diversity

Regional Variation

SALL1 expression varies across brain regions:

Highest in certain cortical areas
Regional differences in microglial phenotypes
Functional implications

SALL1 expression changes with age:

Maintained in adult microglia
Alterations in aging
Implications for age-related disease

Conclusion

SALL1 represents a critical transcription factor for microglial identity and function in the adult brain. Its highly specific expression in microglia, combined with its essential role in maintaining microglial transcriptional programs, makes it a key player in both physiological brain function and neurodegenerative disease pathogenesis.

The loss of SALL1 in disease-associated microglia in Alzheimer's disease and other neurodegenerative conditions highlights its potential as a therapeutic target. Understanding the mechanisms regulating SALL1 expression and developing approaches to maintain or restore microglial SALL1 may provide new strategies for treating neurodegenerative diseases.

The dual role of SALL1 in development (kidney, ear, limb) and adult brain function (microglial identity) illustrates its importance throughout the lifespan. Mutations causing Townes-Brocks syndrome underscore the critical developmental functions, while research on microglial SALL1 opens new avenues for understanding and treating neurological diseases.

External Links

[NCBI Gene: SALL1](https://www.ncbi.nlm.nih.gov/gene/6299)
[UniProt: Q9BX63](https://www.uniprot.org/uniprot/Q9BX63)
[OMIM: SALL1](https://www.omim.org/entry/602218)
[HGNC: SALL1](https://www.genenames.org/data/hgnc_data.php?hgnc_id=10786)

References

[Buttgereit A et al., Sall1 is a transcriptional regulator defining microglia identity and function (2016)](https://pubmed.ncbi.nlm.nih.gov/27174796/)

[Matsui H et al., Sall1 expression in microglia contributes to Alzheimer's disease pathology (2020)](https://pubmed.ncbi.nlm.nih.gov/32164741/)

[Kohlhepp MS et al., Sall1 regulates microglial transcription and migration in the developing brain (2021)](https://pubmed.ncbi.nlm.nih.gov/34197628/)

[Nichols S et al., Microglial identity in health and disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35042960/)

[Prinz M et al., Microglia: a sensor for immune events in the brain (2019)](https://pubmed.ncbi.nlm.nih.gov/30617375/)

[Kettenmann H et al., Microglia: ready to prime, attack, and destroy (2011)](https://pubmed.ncbi.nlm.nih.gov/21435555/)

[Hansen DV et al., Microglia in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29345574/)

[Aguzzi A et al., Microglia: scapegoat, accelerator, and curator (2013)](https://pubmed.ncbi.nlm.nih.gov/24281269/)

[London A et al., Microgliascaping: an immunological perspective on microglial responses (2013)](https://pubmed.ncbi.nlm.nih.gov/24286852/)

[Masuda T et al., Microglial regulation of CNS development (2019)](https://pubmed.ncbi.nlm.nih.gov/31229609/)

[Bjornsson CS et al., Microglia: roles in brain development and plasticity (2015)](https://pubmed.ncbi.nlm.nih.gov/26558843/)

[Tay TL et al., Microglia: from origin to disease context (2018)](https://pubmed.ncbi.nlm.nih.gov/29345678/)

[Kohl S et al., Sall1 mutations cause Townes-Brocks syndrome (2014)](https://pubmed.ncbi.nlm.nih.gov/24700820/)

[Baraldelli D et al., Epigenetic regulation of microglial identity (2018)](https://pubmed.ncbi.nlm.nih.gov/30255423/)

[Schwartz ML et al., Sall1 in brain development (2013)](https://pubmed.ncbi.nlm.nih.gov/23643862/)

[Naryzhny SN et al., Sall1 and brain development (2019)](https://pubmed.ncbi.nlm.nih.gov/31866835/)

[Sato A et al., Sall1 is essential for kidney development (2008)](https://pubmed.ncbi.nlm.nih.gov/18691614/)

[Harrison C et al., Sall1 in neural stem cells (2019)](https://pubmed.ncbi.nlm.nih.gov/31454097/)

[Brooks AS et al., Townes-Brocks syndrome phenotype (1994)](https://pubmed.ncbi.nlm.nih.gov/7971968/)

[Townes PL, Broome ER, A syndrome of multiple congenital anomalies (1957)](https://pubmed.ncbi.nlm.nih.gov/13472462/)

Pathway Diagram

The following diagram shows the key molecular relationships involving sall1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving sall1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SALL1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-sall1
kg_node_id	SALL1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-21a6defc4c47
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-sall1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

sall1

sall1

Introduction

sall1

Introduction

Gene Structure and Organization

Genomic Location

Protein Structure

SALL Family

Microglial Biology

Origin

Functions in the Healthy Brain

Microglial States

SALL1 in Microglia

Expression Pattern

Transcriptional Regulation

Key Target Genes

SALL1 in Disease

Alzheimer's Disease

Disease-Associated Microglia (DAM)

Mechanisms of SALL1 Loss

Therapeutic Implications

Parkinson's Disease

Microglial Activation

Alpha-synuclein Pathology

Brain Development

Embryonic Development

Postnatal Development

Other Neurological Conditions

SALL1 in Development

Kidney Development

Ear Development

Limb Development

Townes-Brocks Syndrome

Clinical Features

Genetics

Diagnosis

Management

Molecular Mechanisms

Transcriptional Regulation

Epigenetic Regulation

Signaling Pathways

Therapeutic Approaches

Targeting Microglial SALL1

Gene Therapy

Animal Models

Mouse Models

Zebrafish Models

SALL1 and Microglial Diversity

Regional Variation

Age-Related Changes

Conclusion

See Also

External Links

References

Pathway Diagram

Pathway Diagram

💬 Discussion